Intended for healthcare professionals

News

FDA committee votes to withdraw bevacizumab for breast cancer

BMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d4244 (Published 05 July 2011) Cite this as: BMJ 2011;343:d4244